Genotoxicity of quercetin in the micronucleus assay in mouse bone marrow erythrocytes, human lymphocytes, V79 cell line and identification of kinetochore-containing (CREST staining) micronuclei in human lymphocytes

doi:10.1016/0165-1218(95)90075-6

Mutation Research/Genetic Toxicology

Volume 343, Issues 2–3, June 1995, Pages 85-94

https://doi.org/10.1016/0165-1218(95)90075-6 Get rights and content

Abstract

Quercetin, a mutagenic flavonoid widely distributed in edible plants, was studied for the induction of micronuclei (MN). We have carried out the MN assay in bone marrow polychromatic erythrocytes in mice, in cytokinesis-blocked human lymphocytes and in cytokinesis-blocked V79 cells. MN assay in vitro was performed in the presence and in the absence of S9. To further extend the study, an antikinetochore antibody (CREST staining) was used to distinguish MN containing whole chromosomes (kinetochore positive) from those containing acentric fragments (kinetochore negative). When tested in vivo quercetin failed to induce micronuclei, a result which is in agreement with other published reports. When tested in vitro in V79 cells quercetin clearly induces micronuclei in the absence of S9 and also in the presence of S9 for the highest dose used. When tested in vitro in human lymphocytes quercetin shows a significant induction of micronuclei in the absence and in the presence of S9. The presence of s9 compared to its absence is not significant for any of the systems used. Both in the presence and absence of S9, quercetin appears to behave as a clastogenic agent in human lymphocytes inducing a significant majority of kinetochore-negative MN.

References (37)

A. Antoccia et al.
Cytokinesis-block micronucleus assay with kinetochore detection in colchicine treated human fibroblasts
Mutation Res.
(1993)
J.P. Brown et al.
Mutagenicity of plant flavonols in the Salmonella/mammalian microsome test. Activation of flavonol glycosides by mixed glycosidases from rat faecal bacteria and other sources
Mutation Res.
(1979)
J.P. Brown
A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds
Mutation Res.
(1980)
J.H. Carver et al.
Genetic effects of flavonol quercetin, kaempferol and galangin on Chinese hamster ovary cells in vitro
Mutation Res.
(1983)
F. Degrassi et al.
Immunofluorescence staining of kinetochores in micronuclei: a new assay for the detection of aneuploidy
Mutation Res.
(1988)
D.A. Eastmond et al.
Kinetochore localisation in micronucleated cytokinesis-blocked Chinese hamster ovary cells: a new and rapid assay for identifying aneuploidy-inducing agents
Mutation Res.
(1989)
J.F. Hatcher et al.
Factors affecting the mutagenic activity of quercetin for Salmonella typhimurium. TA 98: metals ions; antioxidants and pH
Mutation Res.
(1985)
J.T. MacGregor et al.
Mutagenicity of plant flavonoids: structural requirements for mutagenic activity in Salmonella typhimurium
Mutation Res.
(1978)
M.L. Meltz et al.
Activity of the plant flavonol quercetin in the mouse lymphoma L51178 YTK⁺⁺ mutation, DNA single strand break, an BALB/c3T3 chemical transformation assay
Mutation Res.
(1981)
M. Nakayasu et al.
Mutagenicity of quercetin in Chinese hamster lung cells in culture
Mutation Res.
(1986)

M. Ochiai et al.

Superoxide dismutase acts as an enhancing factor for quercetin mutagenesis in rat-liver cytosol by preventing its decomposition

Mutation Res.

(1984)

R. Popp et al.

Induction of sister-chromatid exchanges (SCE), polyploidy, and micronuclei by plant flavonoids in human lymphocyte cultures. A comparative study of 19 flavonoids

Mutation Res.

(1991)

J. Rueff et al.

Oxygen species and the genotoxicity of quercetin

Mutation Res.

(1992)

R.K. Sahu et al.

Genetic Toxicological testing of some plant flavonoids by the micronucleus test

Mutation Res.

(1981)

J.C.M. Van der Hoeven et al.

Genotoxicity of quercetin in cultured mammalian cells

Mutation Res.

(1984)

R. Vrijsen et al.

Metabolic activation of quercetin mutagenicity

Mutation Res.

(1990)

B.T. Zhu et al.

Catechol-O-methyltransferase-catalysed rapid O-methylation of mutagenic flavonoids

J. Biol. Chem.

(1994)

H.U. Aeschbacher et al.

Nonmutagenicity in vivo of the food flavonol quercetin

Nutr. Cancer

(1982)

Cited by (83)

Quercetin modulates signal transductions and targets non-coding RNAs against cancer development
2023, Cellular Signalling
In recent decades, various investigations have indicated that natural compounds have great potential in the prevention and treatment of different chronic disorders including different types of cancer. As a bioactive flavonoid, Quercetin (Qu) is a dietary ingredient enjoying high pharmacological values and health-promoting effects due to its antioxidant and anti-inflammatory characterization. Conclusive in vitro and in vivo evidence has revealed that Qu has great potential in cancer prevention and development. Qu exerts its anticancer influences by altering various cellular processes such as apoptosis, autophagy, angiogenesis, metastasis, cell cycle, and proliferation. In this way, Qu by targeting numerous signaling pathways as well as non-coding RNAs regulates several cellular mechanisms to suppress cancer occurrence and promotion. This review aimed to summarize the impact of Qu on the molecular pathways and non-coding RNAs in modulating various cancer-associated cellular mechanisms.
A review on pharmacological activities and synergistic effect of quercetin with small molecule agents
2021, Phytomedicine
Quercetin is a natural flavonoid, which widely exists in nature, such as tea, coffee, apples, and onions. Numerous studies have showed that quercetin has multiple biological activities such as anti-oxidation, anti-inflammatory, and anti-aging. Hence, quercetin has a significant therapeutic effect on cancers, obesity, diabetes, and other diseases. In the past decades, a large number of studies have shown that quercetin combined with other agents can significantly improve the overall therapeutic effect, compared to single use.
This work reviews the pharmacological activities of quercetin and its derivatives. In addition, this work also summarizes both in vivo and in vitro experimental evidence for the synergistic effect of quercetin against cancers and metabolic diseases.
An extensive systematic search for pharmacological activities and synergistic effect of quercetin was performed considering all the relevant literatures published until August 2021 through the databases including NCBI PubMed, Scopus, Web of Science, and Google Scholar. The relevant literatures were extracted from the databases with following keyword combinations: "pharmacological activities" OR "biological activities" OR "synergistic effect" OR "combined" OR "combination" AND "quercetin" as well as free-text words.
Quercetin and its derivatives possess multiple pharmacological activities including anti-cancer, anti-oxidant, anti-inflammatory, anti-cardiovascular, anti-aging, and neuroprotective activities. In addition, the synergistic effect of quercetin with small molecule agents against cancers and metabolic diseases has also been confirmed.
Quercetin cooperates with agents to improve the therapeutic effect by regulating signal molecules and blocking cell cycle. Synergistic therapy can reduce the dose of agents and avoid the possible toxic and side effects in the treatment process. Although quercetin treatment has some potential side effects, it is safe under the expected use conditions. Hence, quercetin has application value and potential strength as a clinical drug. Furthermore, quercetin, as the main effective therapeutic ingredient in traditional Chinese medicine, may effectively treat and prevent coronavirus disease 2019 (COVID-19).
Genotoxicity evaluation of nutraceuticals
2021, Nutraceuticals: Efficacy, Safety and Toxicity
Herbal supplements, a type of dietary supplement containing one or more herbs, have been used worldwide by individuals attempting to improve their health. Nutraceuticals, defined as a fortified food or dietary supplement, should provide medical or health benefits to those individuals consuming them. However, there is no regulatory definition of nutraceuticals, therefore there is no requirement for manufacturers of nutraceuticals to prove their efficacy or safety. Recently, clear evidence of carcinogenicity was demonstrated for several popular herbal extracts in 2-year bioassays by the National Toxicology Program which has raised concerns about their safety. In this chapter the authors summarize recent findings on the genotoxic effects of three prevalent herbal supplements: Aloe vera, Ginkgo biloba, and goldenseal, with the focus on standard genotoxicity assays. In general, there is a paucity of genotoxicity data for herbal extracts, and recent studies have focused on the mutagenicity of their key chemical ingredients. Currently, a need exists for a comprehensive understanding of risk versus efficacy profiles, standardization of chemical components, and systematic clinical trials for safe application of herbal products.
Cytotoxicity, genotoxicity and gene expression changes elicited by exposure of human hepatic cells to Ginkgo biloba leaf extract
2017, Food and Chemical Toxicology
Citation Excerpt :
However, neither DNA damage and gene mutations in liver, nor micronuclei in bone marrow appeared to be increased in mice exposed to a Ginkgo biloba extract up to 2000 mg/kg bw/day (Maeda et al., 2014). More data are available on the genotoxicity of specific constituents of the extract, with quercetin (Resende et al., 2012; Caria et al., 1995; Lin et al., 2014; Zhang et al., 2015) and kaempferol (Lin et al., 2014; Zhang et al., 2015) being the most in vitro active compounds. Further to genotoxicity, also toxicity endpoints have been evaluated in cell lines treated with Ginkgo biloba extract, including kidney (Hecker et al., 2002), lymphoma (Lin et al., 2014), skin (Hecker et al., 2002; Wang et al., 2015) and stomach (Bai et al., 2015) cells.
The use of Ginkgo biloba leaf extract as nutraceutical is becoming increasingly common. As a consequence, the definition of a reliable toxicological profile is a priority for its safe utilization. Recently, contrasting data have been reported on the carcinogenic potential of Ginkgo biloba extract in rodent liver. We measured viability, Reactive Oxygen Species (ROS), apoptosis, colony-forming efficiency, genotoxicity by comet assay, and gene expression changes associated with hepato-carcinogenicity in human cells of hepatic origin (HepG2 and THLE-2) treated with different concentrations (0.0005–1.2 mg/mL) of Ginkgoselect^®Plus. Our analyses highlighted a decrease of cell viability, not due to apoptosis, after treatment with high doses of the extract, which was likely due to ROS generation by a chemical reaction between extract polyphenols and some components of the culture medium. Comet assay did not detect genotoxic effect at any extract concentration. Finally, the array analysis detected a slight decrease in the expression of only one gene (IGFBP3) in Ginkgo-treated THLE-2 cells as opposed to changes in 28 genes in Aflatoxin B1 treated-cells. In conclusion, our results did not detect any significant genotoxic or biologically relevant cytotoxic effects and gross changes in gene expression using the Ginkgo extract in the hepatic cells tested.
The cytokinesis-block micronucleus (CBMN) assay in human populations exposed to styrene: A systematic review and meta-analysis
2016, Mutation Research - Reviews in Mutation Research
Citation Excerpt :
The stain used in most studies was Giemsa, with the exception of Laffon et al. [28] that used 4,6-diamidino-2-phenylindole (DAPI). Different references were given regarding scoring criteria [39–46]. All but two studies [26,27] scored a minimum of a thousand binucleated lymphocytes per subject.
Styrene is a building-block of several compounds used in a wide array of materials and products. The most important human exposure to this substance occurs in industrial settings, especially among reinforced-plastics industry workers. The effect of occupational exposure to styrene on cytogenetics biomarkers has been previously reviewed with positive association observed for chromosomal aberrations, and inconclusive data for the micronucleus assay. Some limitations were noted in those studies, including inadequate exposure assessment and poor epidemiological design. Furthermore, in earlier studies micronuclei frequency was measured with protocols not as reliable as cytokinesis-block micronucleus (CBMN) assay. Aim of the present systematic review and meta-analysis is to investigate genomic instability and DNA damage as measured by the CBMN assay in lymphocytes of subjects exposed to styrene. A total of 11 studies published between 2004 and 2012 were included in the meta-analysis encompassing 479 styrene-exposed workers and 510 controls. The quality of each study was estimated by a quality scoring system which ranked studies according to the consideration of major confounders, exposure characterization, and technical parameters. An overall increase of micronuclei frequencies was found in styrene-exposure workers when compared to referents (meta-MR 1.34; 95% CI 1.18–1.52), with significant increases achieved in six individual studies. The consistency of results in individual studies, the independence of this result from major confounding factors and from the quality of the study strengthens the reliability of risk estimates and supports the use of the CBMN assay in monitoring genetic risk in styrene workers.
Assessment of Genotoxic Effects of Selected Herbal Dietary Supplements
2016, Nutraceuticals: Efficacy, Safety and Toxicity
The use of herbal dietary supplements is rapidly growing worldwide with the public striving to improve their health. However, clear evidence for carcinogenicity of several popular herbal extracts in 2-year rodent studies by the National Toxicology Program has raised concerns about their safety. In this chapter, the authors summarize recent findings on the genotoxic effects of three prevalent herbal supplements, Aloe vera, Ginkgo biloba, and goldenseal, with a focus on standard genotoxicity assays. In general, there is a paucity of genotoxicity data for herbal extracts. Recent studies of herbal extract genotoxicity focused on the mutagenicity of their key chemical ingredients. Currently, a need exists for comprehensive understanding of risk versus efficacy profiles, standardization of chemical components, and systematic clinical trials for safe application of herbal products.

View all citing articles on Scopus

View full text